类风湿关节炎与心力衰竭住院后90天再入院风险
基于美国2016-2019年全国再入院数据库分析发现,在3,718,425例次心力衰竭指数住院中,32.7%(n=1,214,185)在90天内再入院;类风湿关节炎诊断与90天再入院(aOR 1.16,95%CI 1.13-1.19)及再入院期间院内死亡(aOR 1.12,95%CI 1.04-1.20)显著相关。
要点
- 心力衰竭指数住院后90天内再入院率为32.7%。
- 类风湿关节炎与90天再入院风险升高相关(aOR 1.16,95%CI 1.13-1.19)。
- 类风湿关节炎与再入院期间院内死亡风险升高相关(aOR 1.12,95%CI 1.04-1.20)。
核心结论
- 类风湿关节炎与心力衰竭再住院的90天再入院及院内死亡均存在显著关联。
- 作者提出需探索针对性干预及其他治疗选择,以降低类风湿关节炎合并心力衰竭患者额外的再入院与死亡风险。
研究设计与样本
- 使用美国2016-2019年全国再入院数据库(NRD)的回顾性分析。
主要发现
- 2016-2019年共3,718,425例次心力衰竭指数住院,其中32.7%(n=1,214,185)在指数心力衰竭住院后90天内再入院。
- 多变量校正分析显示,类风湿关节炎诊断与90天再入院显著相关,aOR 1.16(95%CI 1.13-1.19)。
- 多变量校正分析显示,类风湿关节炎诊断与90天再入院期间院内死亡显著相关,aOR 1.12(95%CI 1.04-1.20)。
- 上述结果在额外敏感性分析中得到验证。
关键数值与推荐
- 多变量校正模型调整了患者人口学特征、Deyo-Charlson合并症指数、患者邮编区域家庭收入中位数、主要预期付款方、患者州居住状态、医院教学状态、医院控制类型及医院床位数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To determine the association of rheumatoid arthritis (RA) diagnosis on the risk of 90-day readmissions and in-hospital mortality during readmission episode within 90 days after index heart failure (HF) hospitalization. METHODS: We used the 2016-2019 U.S. Nationwide Readmissions Database (NRD) to examine the association between RA diagnosis and 90-day readmission and in-hospital mortality risk during the 90-day readmission after index HF hospitalization. We performed multivariable-adjusted logistic regression, adjusting for patient demographics, Deyo-Charlson comorbidity index, median household income for patient's ZIP code, primary expected payer, patient state residency status, teaching status of hospital, hospital control, and hospital bed size. We calculated adjusted odds ratios (aOR) and 95 % confidence intervals (95 % CI). RESULTS: Of the 3,718,425 with index HF hospitalizations during 2016-2019, 32.7 % (n = 1,214,185) were readmitted within 90-days of the index heart failure hospitalization. We found that RA diagnosis was significantly associated with both 90-day readmission and in-hospital mortality during readmission within 90 days after index HF hospitalization, with aOR 1.16 (95 % CI, 1.13-1.19), and aOR 1.12 (95 % CI, 1.04-1.20), respectively in multivariable-adjusted analysis. These findings were confirmed in additional sensitivity analysis. CONCLUSION: We demonstrated a significant association of RA with both 90-day readmission and in-hospital mortality in HF rehospitalizations. Targeted interventions and other treatment options need to be explored to reduce the additional risk of readmission and mortality for patients with RA and HF.
引用
- Chandrupatla SR, Singh JA. Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure. Semin Arthritis Rheum. 2025. PMID: 40280050. doi:10.1016/j.semarthrit.2025.152727
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。